← Back to Search

Serial Casting for Burns Contracture

N/A
Recruiting
Led By Bernadette Nedelec, PhD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥16 years old
Burn survivors with >15% loss of PROM of their PIP, MCP, wrist, or elbow in either: flexion, extension, ulnar deviation or radial deviation
Must not have
Have been diagnosed with heterotopic ossification
Do not understand English or French.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 weeks post intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is investigating the effect of serial casting on scar contractures, range of motion, and self-reported function in adults with upper extremity burn injuries.

Who is the study for?
This trial is for adult burn survivors who have lost more than 15% of their normal range of motion in joints like fingers, wrists, or elbows due to fire, flame, or scald burns. They must understand English or French and be able to follow the study's procedures. People with frostbite, chemical/electrical burns, certain psychiatric/cognitive disorders, neurological injuries from the burn, pre-existing conditions affecting movement, heterotopic ossification or when stretching is not advised cannot join.
What is being tested?
The trial tests a tailored serial casting treatment on adults with upper extremity burn contractures. It compares one week of usual care followed by serial casting if there's no improvement in joint movement. The effects on scar characteristics and self-reported arm function are measured over time and compared against expected outcomes without this intervention.
What are the potential side effects?
While specific side effects are not listed for this conservative treatment approach involving splints and casts designed to improve mobility after burns; potential discomforts may include skin irritation under the cast and temporary stiffness during adjustment periods.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 16 years old or older.
Select...
I am a burn survivor with significant movement loss in my hand or arm.
Select...
I have had a burn injury caused by fire, flame, or scalding.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with bone growth in abnormal places.
Select...
I cannot understand English or French.
Select...
I have had frostbite, chemical, or electrical burn injuries.
Select...
I have a condition that limits my movement due to muscle or nerve issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 weeks post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 weeks post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Active range of motion changes
Passive range of motion changes
Secondary study objectives
Patient reported upper-extremity function changes
Scar patient satisfaction
Skin Elasticity Changes
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Serial casted jointExperimental Treatment1 Intervention
Tailored serial casting intervention following 1 week of usual care

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
378 Previous Clinical Trials
131,539 Total Patients Enrolled
Bernadette Nedelec, PhDPrincipal InvestigatorCRCHUM
2 Previous Clinical Trials
31 Total Patients Enrolled

Media Library

Tailored serial casting intervention Clinical Trial Eligibility Overview. Trial Name: NCT05425433 — N/A
Scar Research Study Groups: Serial casted joint
Scar Clinical Trial 2023: Tailored serial casting intervention Highlights & Side Effects. Trial Name: NCT05425433 — N/A
Tailored serial casting intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05425433 — N/A
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top